Study of Saninova tablets in healthy volunteers
This trial tests how a new tablet called Saninova is processed by the body in healthy adults. It helps researchers understand the right dose and how the drug behaves when taken on an empty stomach.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old and weigh at least 110 pounds (50 kg).
- Your body mass index (BMI) is between 18.5 and 30.0.
- You are generally healthy, based on a medical check-up, blood tests, heart tracing, and chest X-ray.
- You do not smoke, drink alcohol regularly, or use any recreational drugs.
- You are willing to use effective birth control (if male) or are not pregnant, breastfeeding, or able to become pregnant (if female) for the study period and for one week after the last dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new tablet called VV261 in healthy volunteers to see how safe it is and how the body processes it. It is an early study to gather important information before larger trials.
This study tests a new tablet called VV261 in healthy volunteers. It looks at how the drug moves through the body and how safe it is when taken multiple times. It may help show if the drug is promising for future treatments.
This trial tests a new investigational drug called SYH2056 in healthy volunteers to see if it is safe and how the body handles it. It also checks how food affects the drug. Participating may help determine if the drug can be developed for future patients.
This trial tests a new medication called SV003 in healthy people to see if it's safe and how the body processes it. You may be able to join if you are in good health and meet certain weight and lifestyle requirements.
This trial tests a new drug (VB19055) in healthy volunteers to see how safe it is and how the body processes it. Participants will be watched closely and may help find the right dose for future studies.
This study tests a new oral medication, VG290131, in healthy volunteers to see how the body processes it and if it is safe. It is an early-phase trial that requires participants to be in good health and follow specific rules about medications and lifestyle.
Hear when a new Bioavailability and Pharmacokinetics trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.